With a number of licensing agreements with its Chinese parent company, Meitheal Pharmaceuticals is hoping to make a difference in the struggle to fend off antibiotic resistance with branded drugs, ...
Meitheal Pharmaceuticals is growing its specialty biopharmaceutical portfolio through a licensing agreement for a novel antibiotic approved to treat community-acquired bacterial pneumonia. The Chicago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback